Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2026-01-19 @ 10:15 AM
Study NCT ID:
NCT00041067
Status:
COMPLETED
Last Update Posted:
2013-06-06
First Post:
2002-07-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
Sponsor:
SWOG Cancer Research Network
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
CDR0000069440
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |